Cargando…

Optimization of an automated tumor-infiltrating lymphocyte algorithm for improved prognostication in primary melanoma

Tumor-infiltrating lymphocytes (TIL) have potential prognostic value in melanoma and have been considered for inclusion in the American Joint Committee on Cancer (AJCC) staging criteria. However, inter-observer discordance continues to prevent the adoption of TIL into clinical practice. Computationa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chou, Margaret, Illa-Bochaca, Irineu, Minxi, Ben, Darvishian, Farbod, Johannet, Paul, Moran, Una, Shapiro, Richard L., Berman, Russell S., Osman, Iman, Jour, George, Zhong, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983061/ https://www.ncbi.nlm.nih.gov/pubmed/33005020 http://dx.doi.org/10.1038/s41379-020-00686-6

Ejemplares similares

Deletion of PTENP1 pseudogene in human melanoma
por: Poliseno, Laura, et al.
Publicado: (2011)

Intra- and Inter-Tumor Heterogeneity of BRAF(V600E)Mutations in Primary and Metastatic Melanoma
por: Yancovitz, Molly, et al.
Publicado: (2012)

Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial
por: Singh, Baljit, et al.
Publicado: (2014)

Somatic and germline analyses of a long term melanoma survivor with a recurrent brain metastasis
por: Weiss, Sarah, et al.
Publicado: (2015)

Revisiting the association between skin toxicity and better response in advanced cancer patients treated with immune checkpoint inhibitors
por: Gulati, Nicholas, et al.
Publicado: (2020)

BET and BRAF inhibitors act synergistically against BRAF‐mutant melanoma
por: Paoluzzi, Luca, et al.
Publicado: (2016)

Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patients
por: Yu, Jessie Z, et al.
Publicado: (2008)

Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts
por: Weiss, Sarah A., et al.
Publicado: (2016)

An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma
por: Acs, Balazs, et al.
Publicado: (2019)

Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis
por: Lattanzi, Michael, et al.
Publicado: (2018)

Impact of molecular testing in advanced melanoma on outcomes in a tertiary cancer center and as reported in a publicly available database
por: Dimitrova, Maya, et al.
Publicado: (2021)

Clinical outcomes in cancer patients with COVID‐19
por: Sawyers, Amelia, et al.
Publicado: (2021)

Tumor-infiltrating lymphocytes for melanoma immunotherapy
por: Kepp, Oliver, et al.
Publicado: (2023)

The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma
por: Huynh, Chanh, et al.
Publicado: (2011)

Correction: The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma
por: Huynh, Chanh, et al.
Publicado: (2011)

Preexisting immune‐mediated inflammatory disease is associated with improved survival and increased toxicity in melanoma patients who receive immune checkpoint inhibitors
por: Gulati, Nicholas, et al.
Publicado: (2021)

A genome-wide association study of germline variation and melanoma prognosis
por: Chat, Vylyny, et al.
Publicado: (2023)

Systems biology perspectives on the carcinogenic potential of radiation
por: Barcellos-Hoff, Mary Helen, et al.
Publicado: (2014)

Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade
por: Johannet, Paul, et al.
Publicado: (2022)

Melanoma risk loci as determinants of melanoma recurrence and survival
por: Rendleman, Justin, et al.
Publicado: (2013)

Angiosarcoma of the Breast Masquerading as Hemangioma: Exploring Clinical and Pathological Diagnostic Challenges
por: Frey, Jordan D, et al.
Publicado: (2015)

Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients
por: Peters, Brandilyn A., et al.
Publicado: (2019)

Immunomodulatory germline variation associated with the development of multiple primary melanoma (MPM)
por: Ferguson, Robert, et al.
Publicado: (2019)

The antigen specific composition of melanoma tumor infiltrating lymphocytes?
por: Hadrup, Sine Reker
Publicado: (2012)

Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
por: Fortes, Cristina, et al.
Publicado: (2015)

Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma
por: Maibach, Fabienne, et al.
Publicado: (2020)

Tumor-Infiltrating Lymphocyte Therapy in Melanoma: Facts to the Future
por: Betof Warner, Allison, et al.
Publicado: (2023)

Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms
por: Aung, Thazin Nwe, et al.
Publicado: (2022)

2081: Phenotypic characterization of the CD4+ T-cell response during anti-CTLA4 therapy with ipilimumab in melanoma patients
por: Sherani, Farha, et al.
Publicado: (2018)

Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy
por: Moogk, Duane, et al.
Publicado: (2014)

Bacteroides vulgatus and Bacteroides dorei predict immune-related adverse events in immune checkpoint blockade treatment of metastatic melanoma
por: Usyk, Mykhaylo, et al.
Publicado: (2021)

Expansion and Characterization of Human Melanoma Tumor-Infiltrating Lymphocytes (TILs)
por: Nguyen, Linh T., et al.
Publicado: (2010)

Characterization of Human γδ T Lymphocytes Infiltrating Primary Malignant Melanomas
por: Cordova, Adriana, et al.
Publicado: (2012)

Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma
por: Sarnaik, Amod A., et al.
Publicado: (2021)

Poor Lymphocyte Infiltration to Primary Tumors in Acral Lentiginous Melanoma and Mucosal Melanoma Compared to Cutaneous Melanoma
por: Nakamura, Yoshiyuki, et al.
Publicado: (2020)

Increased shedding of HU177 correlates with worse prognosis in primary melanoma
por: Hamilton, Heather K, et al.
Publicado: (2010)

Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes
por: Håkansson, A, et al.
Publicado: (2001)

S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes
por: Svane, I, et al.
Publicado: (2014)

Reprogramming of Melanoma Tumor-Infiltrating Lymphocytes to Induced Pluripotent Stem Cells
por: Saito, Hidehito, et al.
Publicado: (2016)

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients
por: Saint-Jean, Mélanie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_53bh6d9il8u70vaanjuakd89r0